Last €33.77 EUR
Change Today -0.205 / -0.60%
Volume 0.0
8AK On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:04 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gordon G. Pugh

Chief Operating Officer, Chief Risk Officer and Senior Vice President, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

56--
As of Fiscal Year 2012

Background*

Mr. Gordon G. Pugh has been the Chief Operating Officer and Senior Vice President of Alkermes Plc (Alkermes Inc.) since May 22, 2007 and its Chief Risk Officer since September 2011. Mr. Pugh is responsible for leading all areas related to the quality manufacture of products, management of supply chains and operation of Alkermes sites. Mr. Pugh served as Vice President of Operations at Alkermes Plc since 2002. He has BS in Microbiology from Cornell University and an MBA ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Cornell University
MBA
Northeastern University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €33.77 EUR -0.205

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.